Is BRIBF or JEPQ a better dividend investment in 2026?

BRIBF currently yields 1062.70% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: BRIBF offers higher current income.

What is the dividend yield difference between BRIBF and JEPQ?

BRIBF has a forward dividend yield of 1062.70% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 1051.60 percentage points.

Home › Compare › BRIBF vs JEPQ

BRIBF vs JEPQ: Dividend Comparison 2026

BRIBF yields 1062.70% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BRIBF wins by $32084463.95M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BRIBF

● Live price

1062.70%

Share price

$0.19

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$32084464.00M

Annual income

$27,073,008,093,454.87

Full BRIBF calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — BRIBF vs JEPQ

📍 BRIBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BRIBF	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BRIBF + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BRIBF pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRIBF

Annual income on $10K today (after 15% tax)

$90,329.44/yr

After 10yr DRIP, annual income (after tax)

$23,012,056,879,436.64/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, BRIBF beats the other by $23,012,056,877,606.94/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRIBF + JEPQ for your $10,000?

BRIBF: 50%JEPQ: 50%

100% JEPQ50/50100% BRIBF

Portfolio after 10yr

$16042232.02M

Annual income

$13,536,504,047,803.72/yr

Blended yield

84.38%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRIBF buys

JEPQ buys

No recent congressional trades found for BRIBF or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBRIBFJEPQ

Forward yield	1062.70% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$32084464.00M ✓	$44.8K
Annual income after 10y	$27,073,008,093,454.87 ✓	$2,152.59
Total dividends collected	$31704729.30M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: BRIBF vs JEPQ ($10,000, DRIP)

Year	BRIBF Portfolio	BRIBF Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$116,970	$106,269.93	$11,930	$1,110.39	+$105.0K → BRIBF
2	$1,286,876	$1,161,718.25	$14,133	$1,224.34	+$1.27M → BRIBF
3	$13,321,776	$11,944,818.28	$16,632	$1,340.46	+$13.31M → BRIBF
4	$129,817,926	$115,563,625.92	$19,454	$1,457.97	+$129.80M → BRIBF
5	$1,191,375,681	$1,052,470,500.56	$22,626	$1,576.08	+$1191.35M → BRIBF
6	$10,301,704,979	$9,026,933,000.21	$26,175	$1,694.09	+$10301.68M → BRIBF
7	$83,971,400,363	$72,948,576,035.34	$30,133	$1,811.32	+$83971.37M → BRIBF
8	$645,568,504,677	$555,719,106,288.88	$34,531	$1,927.17	+$645568.47M → BRIBF
9	$4,683,603,649,023	$3,992,845,349,018.69	$39,403	$2,041.08	+$4683603.61M → BRIBF
10	$32,084,463,997,910	$27,073,008,093,454.87	$44,787	$2,152.59	+$32084463.95M → BRIBF

BRIBF vs JEPQ: Complete Analysis 2026

BRIBF — Stock

Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company develops BRII-778 and BRII-732, which are in phase I clinical trials for the treatment of HIV patients; BRII-179 and BRII-835, which are in Phase 2 to evaluate the combination of these two HBV mechanisms for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 1b/2a; BRII-835, which has completed Phase-2 for patients with chronic HBV infection; and Amubarvimab/romlusevimab combination therapy for the treatment of COVID-19. It also develops BRII-296 for the treatment of PPD; BRII-297 for treatment of various depressive disorders; BRII-636, BRII-672, and BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for the treatment of MDR/XDR tuberculosis and non-tuberculosis mycobacteria. The company was incorporated in 2017 and is based in Beijing, China.

Full BRIBF Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this BRIBF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRIBF vs SCHD BRIBF vs JEPI BRIBF vs O BRIBF vs KO BRIBF vs MAIN BRIBF vs XYLD BRIBF vs QYLD BRIBF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.